Andurox Pharmaceutical Private Limited
About Andurox Pharmaceutical Private Limited
Data last updated:
Andurox Pharmaceutical Private Limited is a private limited company based in Indore, Madhya Pradesh, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 09 January 2023.
The company is registered with the Registrar of Companies (ROC), Gwalior, under CIN U24100MP2023PTC064318. Its GSTIN is 23AAYCA2065J1ZE (Madhya Pradesh).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Dharmendra and Hemant Vyas.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at B – 18 Shivdham Colony Sector C, Indore, Madhya Pradesh, India – 452001.
As per the financials filed for FY 2025, the company reported a revenue of ₹93.29 Lakh, a growth of 118% compared to the previous year. For the same year it recorded a net profit of ₹80,105 (net margin 0.9%) and EBITDA of ₹81,759 (EBITDA margin 0.9%).
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Andurox Pharmaceutical Private Limited's registered office is in Indore, Madhya Pradesh.
- Registered AddressB – 18 Shivdham Colony Sector C, Indore, Madhya Pradesh, India – 452001
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Andurox Pharmaceutical is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale trade, except of motor vehicles and motorcycles.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 46 | Wholesale trade, except of motor vehicles and motorcycles |
To see the full business activity and turnover split of Andurox Pharmaceutical Private Limited, buy the company report.
Financials of Andurox Pharmaceutical Private Limited
FY 2025 filings availableAndurox Pharmaceutical Private Limited reported revenue of ₹93.29 Lakh (up 118% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 118% in the latest year. EBITDA rose 976% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | ₹81,759 | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | ₹80,105 | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | 0.9% | ||
| Net Profit Margin | 0.9% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Andurox Pharmaceutical Private Limited, buy the company report.
Board of directors of Andurox Pharmaceutical Private Limited
Andurox Pharmaceutical has 5 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Dharmendra | Director | 18 Oct 2023 | 3 Years 0 Months | Current |
| Hemant Vyas | Director | 18 Oct 2023 | 3 Years 0 Months | Current |
| Jeevan Babele | Director | 18 Oct 2023 | 3 Years 0 Months | Current |
| Arun Kumar Patidar | Director | 18 Oct 2023 | 3 Years 0 Months | Current |
| Durgesh Bhadoriya | Director | 09 Jan 2023 | 3 Years 9 Months | Current |
Legal cases
No court or tribunal cases involving Andurox Pharmaceutical Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Andurox Pharmaceutical Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Andurox Pharmaceutical has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 23AAYCA2065J1ZE | Madhya Pradesh | Active | 25 Jan 2023 |
To see the full GST registrations and return filing status of Andurox Pharmaceutical Private Limited, buy the company report.
Recent activity
Andurox Pharmaceutical Private Limited has 10 board changes on record since 2023: 5 appointments and 5 cessations. The latest: Arun Kumar Patidar ceased to be Additional Director on 23 Nov 2023.
1 earlier event is in the company report.
Frequently asked questions
Andurox Pharmaceutical is an active private limited company based in Indore, Madhya Pradesh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 09 January 2023 (3+ years old) and is registered under CIN U24100MP2023PTC064318.
Andurox Pharmaceutical has 5 current directors:
- Dharmendra - Director
- Hemant Vyas - Director
- Jeevan Babele - Director
- Arun Kumar Patidar - Director
- Durgesh Bhadoriya - Director
The latest financial statements of Andurox Pharmaceutical on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2023 are in the company report.
The GSTIN of Andurox Pharmaceutical is 23AAYCA2065J1ZE, registered in Madhya Pradesh.
The CIN (Corporate Identification Number) of Andurox Pharmaceutical is U24100MP2023PTC064318. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Andurox Pharmaceutical was incorporated on 09 January 2023, making it 3+ years old. It is registered with the Registrar of Companies, Gwalior.
Arun Kumar Patidar ceased to be Additional Director on 23 Nov 2023. Dharmendra ceased to be Additional Director on 23 Nov 2023. Hemant Vyas ceased to be Additional Director on 23 Nov 2023. Andurox Pharmaceutical has 10 board changes on record in total.
The registered office of Andurox Pharmaceutical is at B – 18 Shivdham Colony Sector C, Indore, Madhya Pradesh, India – 452001.
Andurox Pharmaceutical operates in the pharma industry, in the drug formulation and development segment.
The compliance status of Andurox Pharmaceutical is compliant as of 31 July 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
